BACKGROUND: Although self-efficacy (SE) and outcome expectancy (OE) have been well researched as predictors of outcome, few studies have investigated changes in these variables across treatments. We evaluated changes in OE and SE throughout treatment as predictors of outcomes in a large sample with panic disorder, generalized anxiety disorder, social anxiety disorder, or posttraumatic stress disorder. We hypothesized that increases in SE and OE would predict reductions in anxiety and depression as well as improvement in functioning. METHODS:Participants (mean age = 43.3 years, SD = 13.2, 71.1% female, 55.5% white) were recruited from primary care centers throughout the United States and were randomized to receive either Coordinated Anxiety Learning and Management (CALM) treatment - composed of cognitive behavioral therapy, psychotropic medication, or both - or usual care. SE and OE ratings were collected at each session for participants in the CALM treatment (n = 482) and were entered into a structural equation model as predictors of changes in Brief Symptom Inventory, Anxiety Sensitivity Index, Patient Health Questionnaire (PHQ), and Sheehan Disability Scale outcomes at 6, 12, and 18 months after baseline. RESULTS: The best-fitting models predict symptom levels from OE and SE and not vice versa. The slopes and intercept of OE significantly predicted change in each outcome variable except PHQ-8. The slope and intercept of SE significantly predicted change in each outcome variable. CONCLUSION: Over and above absolute level, increases in SE and OE were significant predictors of decreases in symptoms and increases in functioning. Implications for treatment are discussed, as well as future directions of research.
RCT Entities:
BACKGROUND: Although self-efficacy (SE) and outcome expectancy (OE) have been well researched as predictors of outcome, few studies have investigated changes in these variables across treatments. We evaluated changes in OE and SE throughout treatment as predictors of outcomes in a large sample with panic disorder, generalized anxiety disorder, social anxiety disorder, or posttraumatic stress disorder. We hypothesized that increases in SE and OE would predict reductions in anxiety and depression as well as improvement in functioning. METHODS:Participants (mean age = 43.3 years, SD = 13.2, 71.1% female, 55.5% white) were recruited from primary care centers throughout the United States and were randomized to receive either Coordinated Anxiety Learning and Management (CALM) treatment - composed of cognitive behavioral therapy, psychotropic medication, or both - or usual care. SE and OE ratings were collected at each session for participants in the CALM treatment (n = 482) and were entered into a structural equation model as predictors of changes in Brief Symptom Inventory, Anxiety Sensitivity Index, Patient Health Questionnaire (PHQ), and Sheehan Disability Scale outcomes at 6, 12, and 18 months after baseline. RESULTS: The best-fitting models predict symptom levels from OE and SE and not vice versa. The slopes and intercept of OE significantly predicted change in each outcome variable except PHQ-8. The slope and intercept of SE significantly predicted change in each outcome variable. CONCLUSION: Over and above absolute level, increases in SE and OE were significant predictors of decreases in symptoms and increases in functioning. Implications for treatment are discussed, as well as future directions of research.
Authors: Susan R Tate; Johnny Wu; John R McQuaid; Kevin Cummins; Chris Shriver; Marketa Krenek; Sandra A Brown Journal: Psychol Addict Behav Date: 2008-03
Authors: Raphael D Rose; Ariel J Lang; Stacy Shaw Welch; Laura Campbell-Sills; Denise A Chavira; Greer Sullivan; Cathy Sherbourne; Alexander Bystritsky; Murray B Stein; Peter P Roy-Byrne; Michelle G Craske Journal: Gen Hosp Psychiatry Date: 2011-06-08 Impact factor: 3.238
Authors: Laura Campbell-Sills; Sonya B Norman; Michelle G Craske; Greer Sullivan; Ariel J Lang; Denise A Chavira; Alexander Bystritsky; Cathy Sherbourne; Peter Roy-Byrne; Murray B Stein Journal: J Affect Disord Date: 2008-05-16 Impact factor: 4.839
Authors: S M Sotsky; D R Glass; M T Shea; P A Pilkonis; J F Collins; I Elkin; J T Watkins; S D Imber; W R Leber; J Moyer Journal: Am J Psychiatry Date: 1991-08 Impact factor: 18.112
Authors: Jonathan Shuter; Alyson B Moadel; Ryung S Kim; Andrea H Weinberger; Cassandra A Stanton Journal: Nicotine Tob Res Date: 2014-08-23 Impact factor: 4.244
Authors: Kathleen M Grubbs; Ann M Cheney; John C Fortney; Carrie Edlund; Xiaotong Han; Patricia Dubbert; Cathy D Sherbourne; Michelle G Craske; Murray B Stein; Peter P Roy-Byrne; J Greer Sullivan Journal: Psychiatr Serv Date: 2014-12-15 Impact factor: 3.084
Authors: Krystal M Lewis; Chika Matsumoto; Elise Cardinale; Emily L Jones; Andrea L Gold; Argyris Stringaris; Ellen Leibenluft; Daniel S Pine; Melissa A Brotman Journal: J Child Adolesc Psychopharmacol Date: 2020-03-11 Impact factor: 2.576
Authors: John R Keefe; Jay Amsterdam; Qing S Li; Irene Soeller; Robert DeRubeis; Jun J Mao Journal: J Psychiatr Res Date: 2016-09-30 Impact factor: 4.791
Authors: Shannon Sauer-Zavala; James F Boswell; Kate H Bentley; Johanna Thompson-Hollands; Todd J Farchione; David H Barlow Journal: Cognit Ther Res Date: 2017-04-25
Authors: Henry R Kranzler; Stephen Armeli; Reagan Wetherill; Richard Feinn; Howard Tennen; Joel Gelernter; Jonathan Covault; Timothy Pond Journal: Addict Biol Date: 2014-12-15 Impact factor: 4.280